Lingmei Kong
Key Laboratory Of Medicinal Chemistry For Natural Resource, Yunnan Key Laboratory Of Research And Development For Natural Products
Kunming, 650500, China
Kunming, 650500, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold.
Journal: Journal of medicinal chemistry
Published: February 20, 2026
β-carboline derivative Z86 alleviates pulmonary fibrosis via suppressing TGF-β/Smad signaling.
Journal: Natural products and bioprospecting
Published: January 07, 2026
Berberine promotes β-catenin ubiquitination and inhibits its nuclear translocation by targeting USP22 in colorectal cancers.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 15, 2025
Quercetin, a Natural Dietary Flavonoid, Emerges a Novel USP7 Inhibitor with Anti-colorectal Cancer Effects.
Journal: Biological & pharmaceutical bulletin
Published: October 08, 2025
Manipulating charge transfer dynamics and stabilizing lead bromide octahedra for efficient blue perovskite light-emitting diodes.
Journal: Nature communications
Published: August 03, 2025
Synthesis and antitumor activity of steroid-based imidazolium salts.
Journal: RSC advances
Published: July 30, 2025
Correction to "Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam Scaffold".
Journal: Journal of medicinal chemistry
Published: June 06, 2025
Synthesis and biological activity study of tanshinone I-pyridinium salt derivatives.
Journal: Natural products and bioprospecting
Published: May 06, 2025
Design, Synthesis, and Biological Evaluation of Novel Activators of Human Caseinolytic Protease P with a Pyrazololactam Scaffold.
Journal: Journal of medicinal chemistry
Published: May 03, 2025
Fungal metabolite-based immunotherapy overcomes tumor-associated macrophage immunosuppression.
Journal: Cell reports. Medicine
Published: March 26, 2025
Inhibition of autophagy enhances the sensitivity of ciclopirox olamine in human chronic myelogenous leukemia K562 cells.
Journal: International journal of medical sciences
Published: March 25, 2025
Last Updated: 09/26/2026